Holen Sie sich die Stockscreener-App
0.4951
10.47%
-0.0579
Handel nachbörslich:
.52
0.0249
+5.03%
Milestone Scientific Inc. Aktie (MLSS) Neueste Nachrichten
Transcript: Milestone Scientific Q2 2026 Earnings Conference Call - Sahm
Milestone Scientific’s Global Exposure: Geopolitical and China Risks Threaten Supply Chain and Revenue - TipRanks
Milestone Scientific Inc (MLSS) (Q2 2026) Earnings Call Highligh - GuruFocus
12 Health Care Stocks Moving In Friday's After-Market Session - Benzinga
Milestone Scientific Releases Q2 2026 Financial Results - AlphaStreet
Milestone Scientific Q3 Sales Guidance Misses $2.510M Estimate - scanx.trade
Earnings call transcript: Milestone Scientific posts Q2 2026 revenue growth By Investing.com - Investing.com India
MLSS: Q2 revenue up 22% year-over-year, medical segment surges, 2026 guidance reaffirmed - TradingView
Earnings call transcript: Milestone Scientific posts Q2 2026 revenue growth - Investing.com
Milestone Scientific Inc. Reaffirms Earnings Guidance for the Year Ending December 31, 2026 - marketscreener.com
Milestone Scientific Inc. Q2 2026 Earnings Call Summary - Yahoo Finance
Milestone Scientific Reports 231% Growth in Medical Revenue, Announces VA and DoD Distribution Agreement and Reaffirms 2026 Outlook - Quiver Quantitative
Milestone Scientific Reports Financial Results for Second Quarter 2026 - marketscreener.com
Milestone Scientific Inc (MLSS) (Q2 2026) Earnings Call Highlights: Revenue Surges 22% on ... By GuruFocus - Investing.com Canada
Milestone Scientific Q2 Results: Sales up 22% YoY to $2.841M - scanx.trade
Milestone Scientific (NYSE: MLSS) grows revenue 22% but flags going concern risk - Stock Titan
Milestone Scientific Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com
Earnings To Watch: Milestone Scientific Inc (MLSS) Q2 2026 -- GF Value Sees 13% Upside - Yahoo Finance
Milestone Scientific to host Q2 earnings conference call - Bitget
Milestone Scientific Schedules Second Quarter 2026 Financial Results Conference Call - The Manila Times
Computerized drug-delivery developer sets Aug. 14 results call - Stock Titan
Milestone Scientific Announces Strategic Federal Distribution Partnership with Red One Medical to Expand Commercial Access for the CompuFlo® Epidural System - The Manila Times
Epidural Device to Be Marketed Across VA and Military Systems - Stock Titan
Milestone Scientific signs federal distribution deal with Red One - scanx.trade
Milestone Scientific Inc. (NYSE: MLSS) investors back higher share and equity plan limits - Stock Titan
Milestone Scientific Shareholders Approve Governance and Equity Changes - TipRanks
Milestone Scientific, Inc. Revenue Breakdown – AMEX:MLSS - TradingView
Milestone Scientific Directors Elect Conversion of Bridge Notes - TipRanks
Milestone Scientific (NYSE: MLSS) directors plan bridge note conversions - Stock Titan
Milestone Scientific Inc. (MLSS) Gains 3.13% as Stock Tests Key Resistance at $0.42Volume Breadth - dars.gov.et
Milestone Scientific Inc (MLSS) Cash Flow - TradingKey
Milestone Scientific Inc (MLSS) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
TradingKey - TradingKey
Milestone Scientific Inc (MLSS) Valuation: PE, PB & Fair Value Analysis - TradingKey
Milestone Scientific Inc (MLSS) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Milestone Scientific Inc (MLSS) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
MLSS|Milestone Scientific Inc|Price:0.390|Chg%:-0.008 - TradingKey
MLSS|Milestone Scientific Inc|Price:0.414|Chg%:+0.024 - TradingKey
Milestone Scientific expects Q2 revenue of $2.8M - MSN
MLSS Q1 2026 Earnings: Narrower-Than-Expected Loss Drives Positive SentimentPeak Earnings Alert - dars.gov.et
Top Five Milestones in Space Exploration History - Encyclopedia Britannica
Milestone Scientific Launches First Phase of AI Strategy With Pilot Debut of Milo, an AI-enabled Digital Engagement Platform, at ASPN 2026 - 富途牛牛
Milestone's Milo AI Pilot Will Answer Questions at ASPN 2026 - Stock Titan
Milestone Scientific (MLSS) Gains 3.38% as Stock Tests Key Resistance LevelDip Buy Trade - dars.gov.et
China’s Long March 10B rocket successfully launches—and lands—in a global spaceflight milestone - Scientific American
NewcelX Appoints Diabetes Research Leader Camillo Ricordi to Scientific Advisory Board Following FDA Pre-IND Milestone - Quiver Quantitative
Milestone Scientific Inc. Q1 2026 Earnings: Narrower Than Expected Loss, Stock SlipsOperating Income Trends - dars.gov.et
Price to sales forward of Milestone Scientific, Inc. – AMEX:MLSS - TradingView
MLSSMilestone Scientific Inc Dividends - Finviz
Milestone Scientific Inc. (MLSS) Q1 2026 Earnings: Narrower-Than-Expected Loss Signals Cost Discipline - dars.gov.et
Milestone Scientific (MLSS) Slides 2.34% as Stock Tests Key Support LevelsVolume Weighted Price - dars.gov.et
Benchmark reiterates Milestone Scientific stock Speculative Buy on Q2 beat By Investing.com - Investing.com Nigeria
Benchmark reiterates Milestone Scientific stock Speculative Buy on Q2 beat - Investing.com
MLSS News | MILESTONE SCIENTIFIC INC (NYSEARCA:MLSS) - ChartMill
Milestone Scientific expects Q2 revenue of ~$2.8M, up 21% YoY - scanx.trade
MLSS Reports Strong Revenue Growth in Medical Segment - GuruFocus
Milestone Scientific Reports Preliminary 1H 2026 Revenue of ~$5.0M, +9% YoY; Q2 2026 Revenue of ~$2.8M, +21% YoY - The Manila Times
Milestone Scientific's preliminary Q2 revenue rises on base business expansion - TradingView
Milestone Scientific Inc. Provides Earnings Guidance for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com
symbol__ Stock Quote Price and Forecast - CNN
Price to earnings forward of Milestone Scientific, Inc. – AMEX:MLSS - TradingView
Milestone Scientific (MLSS) Hovers Near Key Support at $0.30 as Selling Pressure PersistsPercent Below MA - DonanımHaber
Milestone Scientific Inc. (MLSS) Q1 2026 Earnings: Narrower-Than-Expected Loss Fails to Lift StockReturn On Capital - dars.gov.et
Enterprise value to revenue forward of Milestone Scientific, Inc. – AMEX:MLSS - TradingView
2.90%
1.18%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):